| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 30, 2012 |
|---|
|
Total Revenue
|
663,694
|
1,283,529
|
1,345,137
|
811,467
| | Cost of Revenue | 267,572 | 516,444 | 586,516 | 311,984 | | |
Gross Profit
|
396,122
|
767,085
|
758,621
|
499,483
| |
|
Operating Expenses |
|
Research Development | 47,185 | 57,686 | 48,472 | 50,113 |
|
Selling General and Administrative | 271,779 | 388,102 | 345,873 | 270,676 |
|
Non Recurring | 49,392 | 89,515 | 89,224 | 70,893 |
|
Others | 17,139 | 31,627 | 25,430 | 21,519 |
|
|
|
Total Operating Expenses | 385,495 | 566,930 | 508,999 | 413,201 | | | |
Operating Income or Loss
|
10,627
|
200,155
|
249,622
|
86,282
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (4,141) | (3,922) | (1,630) | (4,210) |
|
Earnings Before Interest And Taxes | 6,486 | 196,233 | 247,992 | 82,072 |
|
Interest Expense | 22,979 | 22,573 | 23,043 | 22,413 |
|
Income Before Tax | (16,493) | 173,660 | 224,949 | 59,659 |
|
Income Tax Expense | (9,822) | 43,361 | 60,097 | 16,232 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (6,671) | 130,299 | 164,852 | 43,427 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(6,671)
|
130,299
|
164,852
|
43,427
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(6,671)
|
130,299
|
164,852
|
43,427
|
|
0.12%